237 related articles for article (PubMed ID: 12506103)
1. Topical nepafenac inhibits ocular neovascularization.
Takahashi K; Saishin Y; Saishin Y; Mori K; Ando A; Yamamoto S; Oshima Y; Nambu H; Melia MB; Bingaman DP; Campochiaro PA
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):409-15. PubMed ID: 12506103
[TBL] [Abstract][Full Text] [Related]
2. The effects of nepafenac and amfenac on retinal angiogenesis.
Yanni SE; Clark ML; Yang R; Bingaman DP; Penn JS
Brain Res Bull; 2010 Feb; 81(2-3):310-9. PubMed ID: 19897019
[TBL] [Abstract][Full Text] [Related]
3. Blockade of nitric-oxide synthase reduces choroidal neovascularization.
Ando A; Yang A; Nambu H; Campochiaro PA
Mol Pharmacol; 2002 Sep; 62(3):539-44. PubMed ID: 12181430
[TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
5. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP
Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.
Ayalasomayajula SP; Kompella UB
Eur J Pharmacol; 2003 Jan; 458(3):283-9. PubMed ID: 12504784
[TBL] [Abstract][Full Text] [Related]
7. Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development.
Vinores SA; Xiao WH; Aslam S; Shen J; Oshima Y; Nambu H; Liu H; Carmeliet P; Campochiaro PA
J Cell Physiol; 2006 Mar; 206(3):749-58. PubMed ID: 16245301
[TBL] [Abstract][Full Text] [Related]
8. Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization.
Nambu H; Nambu R; Melia M; Campochiaro PA
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3650-5. PubMed ID: 12882819
[TBL] [Abstract][Full Text] [Related]
9. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.
Rakic JM; Lambert V; Devy L; Luttun A; Carmeliet P; Claes C; Nguyen L; Foidart JM; Noël A; Munaut C
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3186-93. PubMed ID: 12824270
[TBL] [Abstract][Full Text] [Related]
10. Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: a randomized trial.
Zanetti FR; Fulco EA; Chaves FR; da Costa Pinto AP; Arieta CE; Lira RP
Indian J Ophthalmol; 2012 Jul; 60(4):277-81. PubMed ID: 22824596
[TBL] [Abstract][Full Text] [Related]
11. Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac.
Lindstrom R; Kim T
Curr Med Res Opin; 2006 Feb; 22(2):397-404. PubMed ID: 16466612
[TBL] [Abstract][Full Text] [Related]
12. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment.
Ohno-Matsui K; Hirose A; Yamamoto S; Saikia J; Okamoto N; Gehlbach P; Duh EJ; Hackett S; Chang M; Bok D; Zack DJ; Campochiaro PA
Am J Pathol; 2002 Feb; 160(2):711-9. PubMed ID: 11839592
[TBL] [Abstract][Full Text] [Related]
13. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
Tobe T; Okamoto N; Vinores MA; Derevjanik NL; Vinores SA; Zack DJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):180-8. PubMed ID: 9430560
[TBL] [Abstract][Full Text] [Related]
14. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
15. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
16. AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat.
Wang F; Rendahl KG; Manning WC; Quiroz D; Coyne M; Miller SS
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):781-90. PubMed ID: 12556414
[TBL] [Abstract][Full Text] [Related]
17. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
Mori K; Gehlbach P; Ando A; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2428-34. PubMed ID: 12091447
[TBL] [Abstract][Full Text] [Related]
18. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Trattler W; McDonald M
Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313
[TBL] [Abstract][Full Text] [Related]
19. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia.
Lukiw WJ; Ottlecz A; Lambrou G; Grueninger M; Finley J; Thompson HW; Bazan NG
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4163-70. PubMed ID: 14507857
[TBL] [Abstract][Full Text] [Related]
20. VEGF is major stimulator in model of choroidal neovascularization.
Kwak N; Okamoto N; Wood JM; Campochiaro PA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3158-64. PubMed ID: 10967078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
